Travelan
Natural health product licensed in Canada
- Licence holder
- Immuron Canada Ltd
- NPN or DIN-HM
- 80046016
- Status
- Active licence
- Licence date
- 5 November 2013
- Revision date
- 3 March 2023
- Form
- Comprimé
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Croscarmellose de sodium, Cellulose - microcrystalline, Dextrose, Coloidal Silicon Dioxide
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 6 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Travelan helps reduce the risk of traveller¿s diarrhea. Helps to support immune function within the upper respiratory tract in adults. Helps to support the immune system in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80046016
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging